At a glance
ClinicalIndex Comparison RecordN/AActive· 912 enrolled
Drug / intervention
Surveyother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
PORTAL: Patient-reported Outcomes After Routine Treatment of Atypical Lesions
In Brief
A clinical study evaluating Survey for Breast Cancer. Active but no longer recruiting, targeting 912 participants across 6 sites.
Detailed Summary
This research study is evaluating how patients feel physically and emotionally after a prior breast biopsy for specific breast conditions (including atypical lesions such as atypical ductal hyperplasia (ADH), atypical lobular hyperplasia (ALH), lobular carcinoma in situ (LCIS), and/or ductal carcinoma in situ (DCIS))
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBreast Cancer
CountriesUnited States
Collaborators--
Timeline
N/AActive
20172018201920202021202220232024202520262027202820292030
First PostedMar 2017
Enrollment StartDec 2017
Primary CompletionMay 2019
TodayJul 2026
Study CompletionFeb 2030
First PostedMar 3, 2017
Enrollment StartDec 1, 2017
Primary CompletionMay 27, 2019
Study CompletionFeb 25, 2030
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 9.3 years ago
Interventions
Surveyother
Select questions will be ask in the survey